Esmolol Impurity 18(Landiolol Impurity 14)
CAS number: 1582797-17-8
Product Code: REF-E09013
Molecular formula: C44H66N6O13
Molecular weight: 887.04
Purity: 95%+
Product nature: Customized for customers
Appearance characteristics: N/A
Storage conditions: 2-8 ° C
Chemical name: ((S)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((S)-2-hydroxy-3-(3-(4-((S)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)-N-(2-(morpholine-4-carboxamido)ethyl)propanamido)propoxy)phenyl)propanoate
Esoprolol Impurity 18 (Randoprolol Impurity 14), Esoprolol Impurity 18 (Randoprolol Impurity 14) Standard, Esoprolol Impurity 18 (Randoprolol Impurity 14) Reference
Hot Tags:Esmolol Impurity 18(Landiolol Impurity 14) , China, suppliers, manufacturers, factory, customized, price, pricelist, in stock。
Synthesis of Esmolol Impurity 18(Landiolol Impurity 14)
Esmolol Impurity 18(Landiolol Impurity 14) Reference Standards,
Complex Impurity Of Esmolol Impurity 18(Landiolol Impurity 14)
Chemical Standards of Esmolol Impurity 18(Landiolol Impurity 14) ，
Characterization Of Unknown Impurities of Esmolol Impurity 18(Landiolol Impurity 14)
Structure Profiling of Esmolol Impurity 18(Landiolol Impurity 14)
Identification of Esmolol Impurity 18(Landiolol Impurity 14)
Isolation & Purification of Impurity of Esmolol Impurity 18(Landiolol Impurity 14)
Difficult of Esmolol Impurity 18(Landiolol Impurity 14)
Instability of Esmolol Impurity 18(Landiolol Impurity 14)
Low-assay of Esmolol Impurity 18(Landiolol Impurity 14)
Complex Impurity Of Chemical Standards of Esmolol Impurity 18(Landiolol Impurity 14)
TOSUN PHARM was established in 1999. In China, it is a collection of drugs, APIs, reference listed drugs, impurities, excipients, intermediates import and export, import registration services, generic drug research and development services, innovative drugs and high-end FDF technology transfer, A group company integrating marketing, academic promotion and cooperative production. With a global procurement, R&D and marketing network, it can quickly meet the needs of product R&D, production and market sales of Chinese and global pharmaceutical companies.
China
